Request Deal Involvement
eFFECTOR Therapeutics went public via a SPAC merger with Locust Walk Acquisition in a $419m deal.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
legal advisors
Latham & Watkins
financial advisors
Locust Walk
financial advisors
Credit Suisse
financial advisors
Stifel
pr advisors
Canale Communications
pr advisors
ICR
legal advisors
Mintz Levin
financial advisors
JMP Securities
financial advisors
Mizuho Securities
financial advisors
Cantor Fitzgerald
or
Principals
target
EFFECTOR THERAPEUTICS
bidder
LOCUST WALK ACQUISITION CORP
bidder
ABINGWORTH MANAGEMENT
bidder
SR ONE LTD
bidder
THE COLUMN GROUP
bidder
US VENTURE PARTNERS (USVP)
bidder
ALTITUDE LIFE SCIENCE VENTURES
bidder
SECTORAL ASSET MANAGEMENT
bidder
PFIZER VENTURES
bidder
OSAGE VENTURE PARTNERS
bidder
ALEXANDRIA VENTURE INVESTMENTS
bidder
BIOMED VENTURES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite